Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Block Listing Application

8 Mar 2016 09:00

RNS Number : 2351R
Premier Veterinary Group PLC
08 March 2016
 

 

 

 

BLOCK LISTING APPLICATION

 

 

London, 8 March 2016: Premier Veterinary Group plc (LSE: PVG) (the "Company") announces that it has made a block listing application to the London Stock Exchange for the admission of up to 1,674,212 ordinary shares of 10 pence each to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities.

 

The block listing application relates to the following:

 

Warrants

 

As part of the arrangements relating to the reverse acquisition by the Company of Premier Veterinary Group Limited (now PVG 2007 Limited) completed in February 2015, warrants were granted over 279,034 ordinary shares of 10 pence each, vesting and becoming exercisable in two equal tranches on 27 February 2016 and 27 February 2017 respectively.

The block listing application is for the total number of shares that could be issued pursuant to the exercise of all of those warrants, representing approximately 2% of the current issued share capital. The application for the admission of these shares has been made in advance for ease of administration.

Further information relating to the warrants can be found in the Company's Annual Report and Accounts 2015 available on its website: www.premiervetgroup.co.uk.

Share options

 

The block listing application also includes a further 1,395,178 shares, being the total number of shares that could be issued pursuant to the exercise of all options currently outstanding under the 2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan (the "EMI Plan"). If all the options were exercised, the shares that would be issued would represent approximately 10% of the current issued share capital.

The application for the admission of these shares has been made in advance for ease of administration as all the outstanding options under the EMI Plan vested and became exercisable on 27 February 2016.

 

 

Shares issued pursuant to the exercise of the warrants and the options under the EMI Plan will rank pari passu with the existing ordinary shares of 10 pence each in the share capital of the Company.

 

It is expected that the block admission will become effective on 9 March 2016.

 

 

Enquiries:

 

Premier Veterinary Group plc

Sue Steven, Company Secretary +44 (0)117 370 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISSSFSUWFMSELD
Date   Source Headline
21st Feb 20117:00 amRNSBoard Change
11th Feb 20117:00 amRNSNotice of Results
8th Feb 20117:00 amRNSDisposal of Majority of Woundcare Business
20th Jan 201112:25 pmRNSHolding(s) in Company
4th Jan 20111:19 pmRNSTotal Voting Rights
16th Dec 20107:00 amRNSChange of Adviser
6th Dec 20109:40 amRNSBlocklisting Interim Review
29th Nov 20101:06 pmRNSHolding(s) in Company
29th Nov 20107:00 amRNSPositive results for pre-clinical product EG013
11th Nov 20107:00 amRNSInterim Management Statement
8th Nov 20102:21 pmRNSHolding(s) in Company
23rd Sep 20104:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20104:35 pmRNSPrice Monitoring Extension
14th Sep 20104:21 pmRNSHolding(s) in Company
14th Sep 20104:19 pmRNSHolding(s) in Company
13th Sep 20103:29 pmRNSDirector/PDMR Shareholding
9th Sep 20107:00 amRNSStrategic Review
31st Aug 201010:33 amRNSTotal Voting Rights
27th Aug 201010:08 amRNSForm 8.5 (EPT/NON-RI)
25th Aug 20107:00 amRNSHalf Yearly Report
20th Aug 20102:27 pmPRNForm 8.3 - Ark Therapeutics Group Plc
19th Aug 201011:35 amRNSForm 8.5 (EPT/NON-RI)
16th Aug 201012:29 pmRNSForm 8.3 - Ark Therapeutics Group plc
16th Aug 20107:00 amRNSForm 8.3 - Ark Therapeutics PLC (Amendment)
13th Aug 20104:24 pmRNSRe EGM
13th Aug 201011:34 amRNSForm 8.5 (EPT/NON-RI)
13th Aug 201011:22 amRNSForm 8.5 (EPT/RI)
13th Aug 201010:30 amRNSForm 8.3 - Ark Therapeutics PLC
11th Aug 201011:35 amRNSForm 8.3 - [Ark Therapeutics Plc]
5th Aug 201012:31 pmRNSForm 8.3 - Ark Therapeutics Group PLC
4th Aug 20104:41 pmRNSSecond Price Monitoring Extn
4th Aug 20104:35 pmRNSPrice Monitoring Extension
4th Aug 201010:00 amRNSForm 8.3 - Ark Therapeutics Group
3rd Aug 201010:47 amRNSForm 8.3 - Ark Therapeutics
30th Jul 201011:22 amRNSForm 8.3 - Ark Therapeutics Plc
29th Jul 201010:34 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 201011:03 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 201010:36 amRNSHolding(s) in Company
28th Jul 201010:30 amRNSForm 8.3 - Ark Therapeutics
28th Jul 201010:01 amRNSHolding(s) in Company
26th Jul 20102:57 pmRNSForm 8.3 - [Ark Therapeutics]
26th Jul 20102:41 pmPRNForm 8.3 - ARK THERAPEUTICS
26th Jul 201011:37 amRNSForm 8.5 (EPT/NON-RI)
23rd Jul 201011:57 amRNSForm 8.5 (EPT/NON-RI)
23rd Jul 201011:15 amRNSForm 8.3 - Ark Therapeutics Group plc
22nd Jul 20102:34 pmPRNForm 8.3 - Ark Theraputics Plc
22nd Jul 201012:54 pmRNSForm 8.3 - Ark Therapeutics Group plc
22nd Jul 201011:19 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 201010:55 amRNSForm 8.3 - Ark Therapeutics Group Plc
21st Jul 20102:41 pmRNSForm 8.3 - Ark Therapeutics Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.